Pompano Beach, Fl, January 7, 2013 – Time Warner Inc. (NYSE: TWX) shares declined 0.41% to $49.17 in the morning hour. The company will report its 2012 fourth-quarter and full-year results on Thursday, January 31, 2013, before the market opens. Senior management will host a conference call beginning at 8:30am ET to discuss the results. The earnings press release will be sent out and available on our Website prior to the market opening.
Will TWX Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://csrnewsdaily.com/c1/?company=TWX
QEP Resources Inc (NYSE: QEP) stock fell 3.19% to $30.37. The company continues to evaluate strategic alternatives to enhance shareholder value with respect to certain of its midstream assets, QEP’s board of directors has authorized the formation of a master limited partnership (MLP) and the preparation and filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of common units of the MLP. The Company expects to file a registration statement with the SEC in the second quarter of 2013.
How Should Investors Trade QEP After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c1/?company=QEP
Eli Lilly & Co. (NYSE: LLY) shares jumped 0.17% to $51.62 after LLY and and Boehringer Ingelheim GmbH have terminated their collaboration on the novel basal insulin analog, LY2605541, and Lilly will reassume sole world-wide development and commercialization rights to the compound. Eli Lilly and Boehringer Ingelheim formed their diabetes alliance in January 2011, centering on four pipeline compounds. The drug companies will continue to jointly develop and market the other assets in the alliance, including Trajenta, empagliflozin and LY2963016, a new insulin glargine product.
Additionally, the company said on Friday that it expects profit in 2013 to increase by more than Wall Street had been forecasting, primarily due to cost controls and improved productivity. It expects 2013 earnings to increase to $3.75 to $3.90 per share excluding items, from a forecast of $3.30 to $3.40 per share in 2012. In 2011, its adjusted earnings were $4.41 per share. Analysts on average forecast earnings of $3.71 for 2013 and $3.36 per share for 2012.
Get Free Special Trend Analysis On LLY Here http://csrnewsdaily.com/c1/?company=LLY
Tesoro Logistics LP (NYSE: TLLP) stock fell 0.51% to $44.77 after the company announced that, while it has not yet closed its books for the fourth quarter of 2012, the Partnership expects to generate Adjusted EBITDA between $25 and $27 million for the fourth quarter 2012, excluding the impact of approximately $1.5 million of transaction costs related to the purchase of the Anacortes Rail Unloading Facility and the announced acquisition of Chevron Pipe Line Company's Northwest Products System.
Get Free Special Trend Analysis On TLLP Here http://csrnewsdaily.com/c1/?company=TLLP
Merck & Co., Inc. (NYSE: MRK) shares climbed 0.29% to $42.09 after the company said the resubmission of the New Drug Application for Sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration or FDA. The company expects the FDA'a review to be completed in the first half of 2013.
Get Free Special Trend Analysis On MRK Here http://csrnewsdaily.com/c1/?company=MRK
About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
Disclaimer:
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact:
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062
323-287-5171
info@pdcincorp.com
www.csrnewsdaily.com